Viewing StudyNCT00003316



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003316
Status: TERMINATED
Last Update Posted: 2013-04-11
First Post: 2000-11-06

Brief Title: Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Sponsor: Gynecologic Oncology Group
Organization: GOG Foundation

Organization Data

Organization: GOG Foundation
Class: NETWORK
Study ID: CDR0000066265
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Gynecologic Oncology Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH